Trevi Therapeutics (TRVI) Capital Expenditures (2018 - 2026)
Trevi Therapeutics' Capital Expenditures came in at $124,000 for Q2 2026, up 21.6% from the prior quarter.
Powered by 
Analysis
Trevi Therapeutics (TRVI) Capital Expenditures (2018 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Trevi Therapeutics reported Capital Expenditures of $238,000; for FY2025, it was $12,000, down 65.7% from FY2024.
- Capital Expenditures has declined in each of the last three years, with a five-year compound annual growth rate of -17.8% (FY2020 to FY2025).
- Going back by year, Capital Expenditures was $35,000 in FY2024 (-74.5%), $137,000 in FY2023 (-13.8%) and $159,000 in FY2022.
- The Q2 2026 figure represents the highest quarterly Capital Expenditures in data going back to Q1 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.32 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 322.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 893.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -321.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -763.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 513.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 140.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 533.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 112.20 Mn |
| 10 | Trevi Therapeutics | 2.04 Bn | 2.04 Bn | - | 124,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 124,000.00 |
| Mar 31, 2026 | 102,000.00 |
| Sep 30, 2025 | 12,000.00 |
| Dec 31, 2024 | 7,000.00 |
| Dec 31, 2023 | 22,000.00 |
| Sep 30, 2023 | 18,000.00 |
| Jun 30, 2023 | 40,000.00 |
| Mar 31, 2023 | 57,000.00 |
| Dec 31, 2022 | 116,000.00 |
| Dec 31, 2020 | 5,000.00 |
| Sep 30, 2020 | 15,000.00 |
| Mar 31, 2019 | 9,000.00 |
| Dec 31, 2018 | 92,000.00 |
| Sep 30, 2018 | -1,000.00 |
| Jun 30, 2018 | 10,000.00 |
| Mar 31, 2018 | 57,000.00 |
API Access
Trevi Therapeutics Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=TRVI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "TRVI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=TRVI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();